Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The 50th Anniversary of the Oxford Self-harm Monitoring System

Influential and impactful Oxford Self-harm Monitoring System had been in place, and continuously funded, for 50 years.

Two researchers from NDCN join global network to unravel the complexity of Parkinson’s disease

Two scientists from NDCN, Professor Andrew Sharott (Team leader) and Professor Laura Parkkinen (Co-Investigator) have been selected for multi-year grants to join the Collaborative Research Network (CRN) an international, multidisciplinary, multi-institutional network working to address high-priority research questions about Parkinson's disease.

Study shows that non-invasive ultrasound shows promise for treating Parkinson’s disease

Oxford researchers have shown for the first time that ultrasound could have similar effects on brain activity in Parkinson’s sufferers as implanted deep brain stimulation (DBS) electrodes. This opens the door to new treatment approaches that could avoid surgery.

Professor Asifa Majid awarded Humboldt Research

Professor Asifa Majid of the Department of Experimental Psychology has been awarded the prestigious Humboldt Research Award by the Alexander von Humboldt Foundation.

New study offers breakthrough in detecting risk for psychosis and bipolar disorders

A study published recently in The Lancet Psychiatry has unveiled a new approach to identifying individuals at risk of developing psychotic disorders or bipolar disorder.

Oxford-Harrington Rare Disease Centre Announces 2025 Scholars

Esther Becker is one of ten recipients of the 2025 Rare Disease Scholar Award, which advances promising discoveries from academic labs into clinical practice.

Cognitive impairment after a stroke calls for tailored recovery treatment shows new study

A major new study recently published in Imaging Neuroscience shows that the brain location of the stroke does not always determine the symptoms.

Simple scoring system could help clinicians identify possible cases of NMDAR-antibody encephalitis

Scientists have identified a key set of symptoms and developed a scoring system to help clinicians in frontline medical and mental health services consider the possibility of a rare form of encephalitis, which can sometimes be mistaken for psychosis.

New research collaboration to tackle ethnic inequalities in perinatal severe mental illness

A ground-breaking new study aims to transform postpartum mental health care for mothers from ethnic minority backgrounds or those living in deprived areas who experience severe mental illness.

New study investigates cause of repetitive negative thoughts

Repetitive negative thoughts will be investigated using a range of cutting-edge brain science techniques as part of a new study led by the University of Oxford and funded by Wellcome.

Six new Professors across Oxford Neuroscience

Congratulations to the following members of our Oxford Neuroscience Community who have been awarded the title of Professor in the recent Recognition of Distinction exercise.

Planning application submitted for a major mental health and medical research campus in Oxford

Plans to transform an NHS site into a major mental health and medical research campus in Headington have been submitted to Oxford City Council by Oxford Health NHS Foundation Trust.

Chronic pain research breakthrough identifies promising drug target

For the first time, a team of researchers have identified a new genetic link to pain, offering a promising drug target to alleviate chronic pain.

Doctors call for improved physical health monitoring for people prescribed psychiatric medication

A major new Lancet Commission has called for people taking psychiatric medications - such as antidepressants, antipsychotics, and mood stabilisers - to receive proactive, ongoing physical health monitoring and support.

Prehistoric teeth used to create historic map of infectious diseases

A research project led jointly by researchers from NDCN, the University of Copenhagen and University of Cambridge shows that large-scale mapping of prehistoric teeth and bones provides new knowledge of present-day infectious diseases. This may, among other things, have an impact on the development of vaccines.

Identifying research priorities for severe paranoia

We talk to lead author David Sher about his paper, which aimed to establish potential research priorities for understanding and treating severe paranoia for the first time.

Award in memory of Dr Valeria Frighi given to psychology trainee Michael Barry

The £1,000 fund was set up to support researchers with an interest in intellectual disabilities.

Load More